Dow Chemical Subsidiary Granted U.S. Patent on Transgenic Bt in Plants
Mycogen Plant Seeds, Inc., an affiliate of Dow AgroSciences LLC, has been granted U.S. patent rights to Transgenic Bt in Plants, according to an announcement issued by the U.S. Patent Office, September 13, 2005. Both Mycogen and Dow AgroSciences are wholly-owned subsidiaries of The Dow Chemical Company.
Produced naturally by soil bacteria, the insecticidal protein Bt (Bacillus thuringiensis) can be expressed in plants so that crops are able to protect themselves against insect pests.
The newly granted patent for Bt in Plants gives Dow broad and exclusive U.S. rights to this technology.
The patent for Bt in Plants was originally filed in 1988, but a decision by the U.S. Patent Office was delayed by interference proceedings brought by another company. These proceedings ran from 1994 to 2003 and were ultimately resolved in Dow's favor.
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.